|
DIXDC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68243197151696E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67399427652981E-12 |
| Normal-vs-Stage2 |
4.78579999962925E-07 |
| Normal-vs-Stage3 |
1.68731695282531E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.507580E-02 |
| Stage1-vs-Stage3 |
7.350400E-01 |
| Stage1-vs-Stage4 |
8.968300E-04 |
| Stage2-vs-Stage3 |
9.720400E-03 |
| Stage2-vs-Stage4 |
1.041630E-04 |
| Stage3-vs-Stage4 |
2.259900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.84297022087776E-14 |
| Normal-vs-AfricanAmerican |
4.64689953183495E-10 |
| Normal-vs-Asian |
1.92768023765666E-12 |
| Caucasian-vs-AfricanAmerican |
9.689400E-01 |
| Caucasian-vs-Asian |
7.197600E-01 |
| AfricanAmerican-vs-Asian |
8.165000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63702384980979E-12 |
| Normal-vs-Female |
1.09134923320653E-13 |
| Male-vs-Female |
2.296400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.69408931327553E-12 |
| Normal-vs-Age(41-60Yrs) |
3.5527136788005E-14 |
| Normal-vs-Age(61-80Yrs) |
5.8599791685765E-12 |
| Normal-vs-Age(81-100Yrs) |
7.64440000000643E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.868600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.429400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.510800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.533200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.996800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.034000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.501900E-02 |
| Classical-VS-Follicular |
4.772200E-04 |
| Classical-VS-Other |
2.295600E-01 |
| Classical-VS-Normal |
2.34257058195908E-14 |
| Tall-VS-Follicular |
4.29840000000237E-05 |
| Tall-VS-Other |
7.333400E-01 |
| Tall-VS-Normal |
1.62625468647093E-12 |
| Follicular-VS-Other |
2.461800E-03 |
| Follicular-VS-Normal |
2.48429999905042E-08 |
| Other-VS-Normal |
1.13939999657475E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.90025772894842E-12 |
| Normal-vs-N1 |
1.11022302462516E-16 |
| N0-vs-N1 |
1.004640E-04 |
|
|
